Ragnar Hovland

发表

Evaluation of a structured pharmacist-led inhalation technique assessment service for patients with asthma and COPD in Norwegian pharmacies.

K. W. Ruud, Stine Wang Rønningen, Per Kristian Faksvåg, 2018, Patient education and counseling.

Drug-related problems and satisfaction among patients receiving pharmacist-led consultations at the initiation of cardiovascular drugs.

S. Bremer, Erik Magnus Sæther, Ragnar Hovland, 2022, Research in social & administrative pharmacy : RSAP.

Gadolinium DO3A derivatives mimicking phospholipids; preparation and in vitro evaluation as pH responsive MRI contrast agents

J. Klaveness, Ragnar Hovland, C. Gløgård, 2001 .

Synthesis and physicochemical characterisation of new amphiphilic gadolinium DO3A complexes as contrast agents for MRI

J. Klaveness, S. Fossheim, Ragnar Hovland, 2000 .

Preparation and in vitro evaluation of GdDOTA-(BOM)4; a novel angiographic MRI contrast agent.

J. Klaveness, Ragnar Hovland, A. Aasen, 2003, Organic & biomolecular chemistry.

A novel series of piperazinyl-pyridine ureas as antagonists of the purinergic P2Y12 receptor.

Jonas Boström, P. Bach, K. Brickmann, 2011, Bioorganic & medicinal chemistry letters.

Preparation and in vitro evaluation of a novel amphiphilic GdPCTA-[12] derivative; a micellar MRI contrast agent.

J. Klaveness, Ragnar Hovland, C. Gløgård, 2003, Organic and biomolecular chemistry.

Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687).

Magnus J. Johansson, Tobias Noeske, Robert D. M. Davies, 2012, Journal of medicinal chemistry.

Liposomes as carriers of amphiphilic gadolinium chelates: the effect of membrane composition on incorporation efficacy and in vitro relaxivity.

Jo Klaveness, J. Klaveness, S. Fossheim, 2002, International journal of pharmaceutics.

Abstract 18507: Icosabutate, a Novel Structurally Enhanced Fatty-acid Increases Hepatic Uptake of Cholesterol and Triglycerides in Conjunction With Increased Hepatic LDL Receptor Expression

E. Pieterman, H. Princen, C. Husberg, 2014 .

Design of small molecule inhibitors of acetyl-CoA carboxylase 1 and 2 showing reduction of hepatic malonyl-CoA levels in vivo in obese Zucker rats.

A. Plowright, Tobias Noeske, V. Schnecke, 2011, Bioorganic & medicinal chemistry.

Effect of a pharmacist‐led intervention on adherence among patients with a first‐time prescription for a cardiovascular medicine: a randomized controlled trial in Norwegian pharmacies

S. Bremer, I. Kristiansen, Per Kristian Faksvåg, 2019, The International journal of pharmacy practice.

Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687).

Magnus J. Johansson, Tobias Noeske, Robert D. M. Davies, 2012, Journal of medicinal chemistry.